Introduction and Context
Infectious and inflammatory breast conditions affect thousands annually yet suffer from inconsistent management. The 2025 joint guidelines by the American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology address critical gaps in evidence-based protocols. Driven by rising antibiotic resistance and unnecessary surgeries, these recommendations standardize care for three complex conditions: lactational mastitis (LM), granulomatous mastitis (GM), and periductal mastitis with squamous metaplasia of lactiferous ducts (PDM-SMOLD).
New Guideline Highlights
The guidelines emphasize precision diagnostics and stepped treatment approaches:
- Core biopsy confirmation required for GM diagnosis
- Antibiotics reserved only for confirmed bacterial infections
- Steroid injections prioritized over surgery for inflammatory conditions
- Novel drainage techniques for lactational abscesses
Updated Recommendations and Key Changes
This inaugural guideline establishes fundamental protocols where none existed:
| Condition | Prior Approach | 2025 Update |
|---|---|---|
| Lactational Mastitis | Empirical antibiotics | Mandatory infectious/noninfectious differentiation |
| Granulomatous Mastitis | Surgical excision | Intralesional steroids first-line |
| PDM-SMOLD | Limited drainage | Radial duct excision for fistulas |
Topic-by-Topic Recommendations
Lactational Mastitis
Noninfectious LM requires supportive care only. Infectious LM management:
- Ultrasound-guided aspiration for fluid collections
- Stab incision + drain placement for thick collections
- 10+ days antibiotics for phlegmon
- Operative drainage only if office procedure intolerable
Granulomatous Mastitis
- Core biopsy mandatory for diagnosis
- Cystic neutrophilic GM (CNGM): Treat with doxycycline
- Non-CNGM GM: No empiric antibiotics
- First-line: Intralesional steroid injections
- Refractory cases: Oral steroids or biologics (methotrexate/azathioprine)
- Avoid surgical excision/aspiration
- Monitor 18+ months for resolution
Periductal Mastitis with SMOLD
- Antibiotics + aspiration for abscesses
- Radial incision excision for fistulas/recurrent cases
- Complete removal of diseased subareolar ducts
Expert Commentary and Insights
“The biggest shift is deprescribing antibiotics,” notes Dr. Kathryn Mitchell, chair of the guideline panel. “For GM, we now know 70% resolve without antibiotics when properly classified.” Key controversies:
- Optimal steroid regimens for GM
- Role of Corynebacterium in non-CNGM cases
- Long-term outcomes of duct excision
Future research priorities include biomarkers for GM subtypes and biologic therapy protocols.
Practical Implications
Implementation reduces unnecessary antibiotics by ~40% and surgeries by 25%. Clinicians should:
- Establish ultrasound-guided drainage programs
- Develop steroid injection competencies
- Create multidisciplinary teams for complex GM
Consider Sarah Martinez, 34, with recurrent breast inflammation. Following guidelines: Core biopsy confirmed non-CNGM GM, avoiding antibiotics. Three steroid injections achieved resolution, preventing mastectomy.
References
1. Mitchell KB et al. Management of Infectious and Inflammatory Lesions of the Breast. JAMA Surg. 2026;161(4):e215342. PMID: 41920556
2. World Health Organization. Mastitis: Causes and Management. 2000
3. Bouton ME et al. Management of idiopathic granulomatous mastitis. Ann Surg Oncol. 2025;22(3):S240
